Cerebrovascular perfusion in marijuana users during a month of monitored abstinence.

Abstract:

OBJECTIVE:To determine possible effects of prolonged marijuana use on the cerebrovascular system during a month of monitored abstinence and to assess how the intensity of current use might have influenced cerebrovascular perfusion in these marijuana users. METHOD:The authors recorded blood flow velocity in the anterior and middle cerebral arteries using transcranial Doppler sonography in three groups of marijuana users who differed in the intensity of recent use (light: n = 11; moderate: n = 23; and heavy: n = 20) and in control subjects (n = 18) to assess the nature and duration of any potential abnormalities. Blood flow velocity was recorded within 3 days of admission and 28 to 30 days of monitored abstinence on an inpatient research unit in order to evaluate subacute effects of the drug and any abstinence-generated changes. RESULTS:Pulsatility index, a measure of cerebrovascular resistance, and systolic velocity were significantly increased in the marijuana users vs control subjects. These increases persisted in the heavy marijuana users after a month of monitored abstinence. CONCLUSIONS:Chronic marijuana use is associated with increased cerebrovascular resistance through changes mediated, in part, in blood vessels or in the brain parenchyma. These findings might provide a partial explanation for the cognitive deficits observed in a similar group of marijuana users.

journal_name

Neurology

journal_title

Neurology

authors

Herning RI,Better WE,Tate K,Cadet JL

doi

10.1212/01.WNL.0000150882.69371.DD

subject

Has Abstract

pub_date

2005-02-08 00:00:00

pages

488-93

issue

3

eissn

0028-3878

issn

1526-632X

pii

64/3/488

journal_volume

64

pub_type

杂志文章
  • Leigh-type neuropathology in Pearson syndrome associated with impaired ATP production and a novel mtDNA deletion.

    abstract::Pearson syndrome is a systemic disorder of oxidative phosphorylation in infants, predominantly affecting the bone marrow and exocrine pancreas and associated with single deletions in mitochondrial DNA (mtDNA). CNS involvement may occur in patients who survive the infantile hematopoietic disorder. We describe a Pearson...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.47.5.1320

    authors: Santorelli FM,Barmada MA,Pons R,Zhang LL,DiMauro S

    更新日期:1996-11-01 00:00:00

  • Competitive inhibition of brain hexokinase by metrizamide.

    abstract::We compared the effect of metrizamide and its parent compound glucosamine on the kinetics of dog brain hexokinase. The Michaelis constant (Km) for glucose rose from 0.065 to 0.15 to 0.28 mM in the presence of 0, 16, and 32 mM metrizamide, respectively. For 0, 1.5, and 3.7 mM glucosamine, the Km values were 0.065, 0.4,...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.32.3.320

    authors: Bertoni JM,Steinman CG

    更新日期:1982-03-01 00:00:00

  • Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

    abstract:OBJECTIVE:To develop a scientifically sound and clinically relevant evidence-based guideline for the treatment of painful diabetic neuropathy (PDN). METHODS:We performed a systematic review of the literature from 1960 to August 2008 and classified the studies according to the American Academy of Neurology classificati...

    journal_title:Neurology

    pub_type: 指南,杂志文章,评审

    doi:10.1212/WNL.0b013e3182166ebe

    authors: Bril V,England J,Franklin GM,Backonja M,Cohen J,Del Toro D,Feldman E,Iverson DJ,Perkins B,Russell JW,Zochodne D,American Academy of Neurology.,American Association of Neuromuscular and Electrodiagnostic Medicine.,American Acade

    更新日期:2011-05-17 00:00:00

  • Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

    abstract:BACKGROUND:Plasma exchange (PE) is used to treat severe episodes of CNS demyelination unresponsive to corticosteroids. Predictors of long-term response are not well known. METHODS:We retrospectively reviewed the medical records of 41 patients consecutively treated by PE between January 1995 and July 2007. The primary ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e3181b879be

    authors: Llufriu S,Castillo J,Blanco Y,Ramió-Torrentà L,Río J,Vallès M,Lozano M,Castellà MD,Calabia J,Horga A,Graus F,Montalban X,Saiz A

    更新日期:2009-09-22 00:00:00

  • Motor activation in multiple system atrophy and Parkinson disease: a PET study.

    abstract:BACKGROUND:Multiple system atrophy (MSA) is an atypical parkinsonian syndrome including cerebellar impairment and poor response to levodopa. We assessed right hand motor activation in patients with MSA before and after an acute levodopa challenge in comparison with patients with PD and healthy volunteers (HVs). METHOD...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e3181f4d78f

    authors: Payoux P,Brefel-Courbon C,Ory-Magne F,Regragui W,Thalamas C,Balduyck S,Durif F,Azulay JP,Tison F,Blin O,Esquerre JP,Rascol O

    更新日期:2010-09-28 00:00:00

  • Evaluation of ambulatory cassette EEG monitoring: III. Diagnostic accuracy compared to intensive inpatient EEG monitoring.

    abstract::We assessed the ability to recognize epileptiform abnormalities on a video review of ambulatory cassette EEGs (A/EEG) by comparing two independent interpretations of an A/EEG to those derived from a routine recording and intensive monitoring by cable telemetry (C/EEG) of the same 40 patients. Both A/EEG readings concu...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.33.7.853

    authors: Ebersole JS,Leroy RF

    更新日期:1983-07-01 00:00:00

  • Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF.

    abstract:OBJECTIVE:In families with autosomal dominant partial epilepsy with auditory features (ADPEAF) with mutations in the LGI1 gene, we evaluated clustering of mutations within the gene and associations of penetrance and phenotypic features with mutation location and predicted effect (truncation or missense). METHODS:We ab...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e318247ccbf

    authors: Ho YY,Ionita-Laza I,Ottman R

    更新日期:2012-02-21 00:00:00

  • Registry studies of long-term multiple sclerosis outcomes: description of key registries.

    abstract:BACKGROUND:Multiple sclerosis (MS) registries can provide valuable insights into the natural history of MS. Key observational findings of the registries include MS patient disability progression rate, predictors of increased disability, and changes in lifespan. MS registries have been established in Canada, the United ...

    journal_title:Neurology

    pub_type: 杂志文章,评审

    doi:10.1212/WNL.0b013e3182050225

    authors: Hurwitz BJ

    更新日期:2011-01-04 00:00:00

  • SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.

    abstract:BACKGROUND:Inherited and de novo mutations in sodium channel genes underlie a variety of channelopathies. Mutations in SCN2A, encoding the brain sodium channel Na(V)1.2, have previously been reported to be associated with benign familial neonatal infantile seizures, febrile seizures plus, and intractable epilepsy of in...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e3181f8812e

    authors: Liao Y,Anttonen AK,Liukkonen E,Gaily E,Maljevic S,Schubert S,Bellan-Koch A,Petrou S,Ahonen VE,Lerche H,Lehesjoki AE

    更新日期:2010-10-19 00:00:00

  • Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model.

    abstract::Using an in vitro blood-nerve barrier (BNB) model, the authors tested the effect of various monoclonal antiganglioside antibodies on BNB function. Only anti-GM1 antibody significantly facilitated BNB leakage in a concentration-dependent, complement-independent manner. This study provided evidence that anti-GM1 antibod...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.55.4.585

    authors: Kanda T,Iwasaki T,Yamawaki M,Tai T,Mizusawa H

    更新日期:2000-08-22 00:00:00

  • Sleep-disordered breathing and respiratory failure in acid maltase deficiency.

    abstract:BACKGROUND:Sleep-disordered breathing (SDB) and respiratory failure (RF) are complications of acid maltase deficiency (AMD), a rare hereditary myopathy. OBJECTIVE:To define the relationship between lung and respiratory muscle function, to establish incidence and patterns of SDB, and to determine daytime predictors of ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.57.7.1290

    authors: Mellies U,Ragette R,Schwake C,Baethmann M,Voit T,Teschler H

    更新日期:2001-10-09 00:00:00

  • Utilization of unconventional treatments by persons with MS: is it alternative or complementary?

    abstract::This cross-sectional mail survey evaluated the prevalence and predictors of unconventional therapy (UT) utilization among 569 community-based people with MS. One-third reported having visited a UT practitioner in the last 6 months. Utilizers tended to report at least one medical comorbidity, earn at least $50,000 a ye...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.52.3.626

    authors: Schwartz CE,Laitin E,Brotman S,LaRocca N

    更新日期:1999-02-01 00:00:00

  • Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

    abstract:BACKGROUND:Galantamine is a reversible, competitive cholinesterase inhibitor that also allosterically modulates nicotinic acetylcholine receptors. These mechanisms of action provided the rationale for a therapeutic trial of galantamine in AD. METHODS:A 6-month, multicenter, double-blind trial was undertaken in 636 pat...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1212/wnl.54.12.2261

    authors: Raskind MA,Peskind ER,Wessel T,Yuan W

    更新日期:2000-06-27 00:00:00

  • Surgical treatment of intractable neonatal-onset seizures: the role of positron emission tomography.

    abstract::We have performed positron emission tomography (PET) with 2-deoxy-2[18F]fluoro-D-glucose (FDG) in eight infants and children (aged 18 days to 5 years) with medically refractory epilepsy of neonatal onset. It was hypothesized that in at least some of these infants a surgical approach (focal resection, cerebral hemisphe...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.38.8.1178

    authors: Chugani HT,Shewmon DA,Peacock WJ,Shields WD,Mazziotta JC,Phelps ME

    更新日期:1988-08-01 00:00:00

  • 11C-methionine PET for differential diagnosis of low-grade gliomas.

    abstract::Management of low-grade gliomas continues to be a challenging task, because CT and MRI do not always differentiate from nontumoral lesions. Furthermore, tumor extent and aggressiveness often remain unclear because of a lack of contrast enhancement. Previous studies indicated that large neutral amino acid tracers accum...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章

    doi:10.1212/wnl.50.5.1316

    authors: Herholz K,Hölzer T,Bauer B,Schröder R,Voges J,Ernestus RI,Mendoza G,Weber-Luxenburger G,Löttgen J,Thiel A,Wienhard K,Heiss WD

    更新日期:1998-05-01 00:00:00

  • Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis.

    abstract::Comprehensive management of patients with multiple sclerosis (MS) includes treatment to modify the disease course and interventions to address the persistent symptoms and consequences of this chronic illness, which can affect patients for decades. Although much excitement and attention accompanies new therapeutic init...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e31818f3da5

    authors: Cohen BA

    更新日期:2008-12-09 00:00:00

  • Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS.

    abstract::The American Academy of Neurology has published a comprehensive review and guidelines for the use of disease-modifying therapies (DMTs) in multiple sclerosis (MS) for the first time since 2002. These guidelines represent the work of MS experts, patients, and guideline experts and are based on their review of randomize...

    journal_title:Neurology

    pub_type: 杂志文章,评审

    doi:10.1212/WNL.0000000000005574

    authors: Corboy JR,Weinshenker BG,Wingerchuk DM

    更新日期:2018-06-12 00:00:00

  • Changes in the ascertainment of multiple sclerosis.

    abstract:OBJECTIVE:With diagnostic criteria alterations, increased MRI availability, and awareness of therapies, temporal changes in incidence and prevalence rates may occur, with an increase in the proportion of mildly affected persons diagnosed with multiple sclerosis (MS). The authors assessed temporal trends in the delay fr...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000178891.20579.64

    authors: Marrie RA,Cutter G,Tyry T,Hadjimichael O,Campagnolo D,Vollmer T

    更新日期:2005-10-11 00:00:00

  • Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.

    abstract::Morphologic findings of thymuses from 32 anti-acetylcholine receptor (AChR)-negative myasthenia gravis patients, 12 with and 20 without antibodies against the muscle-specific kinase (MuSK), were compared with those from 30 AChR-positive subjects. In contrast with the high frequency of thymic hyperplastic changes in AC...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.WNL.0000150587.71497.B6

    authors: Lauriola L,Ranelletti F,Maggiano N,Guerriero M,Punzi C,Marsili F,Bartoccioni E,Evoli A

    更新日期:2005-02-08 00:00:00

  • Apolipoprotein E genotype and memory in the sixth decade of life.

    abstract:BACKGROUND:Virtually all adult studies of APOE genotypes and cognition have included individuals over 60. In older adults, epsilon 4 carriers may manifest greater cognitive asymmetries than non-epsilon 4 carriers even in the absence of overall mean differences. General cognitive ability may also be affected by aging an...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000286941.74372.cc

    authors: Schultz MR,Lyons MJ,Franz CE,Grant MD,Boake C,Jacobson KC,Xian H,Schellenberg GD,Eisen SA,Kremen WS

    更新日期:2008-05-06 00:00:00

  • CSF detection of the 14-3-3 protein in unselected patients with dementia.

    abstract:OBJECTIVE:To determine the usefulness of the 14-3-3 test in patients with dementia of various causes. BACKGROUND:Recent reports have suggested that the detection of the 14-3-3 protein in the CSF of patients with Creutzfeldt--Jakob disease is a highly sensitive and specific marker of the disease that might be used as a...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.56.11.1528

    authors: Burkhard PR,Sanchez JC,Landis T,Hochstrasser DF

    更新日期:2001-06-12 00:00:00

  • Relationship between etiology and covert cognition in the minimally conscious state.

    abstract:OBJECTIVES:Functional neuroimaging has shown that the absence of externally observable signs of consciousness and cognition in severely brain-injured patients does not necessarily indicate the true absence of such abilities. However, relative to traumatic brain injury, nontraumatic injury is known to be associated with...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e318249f764

    authors: Cruse D,Chennu S,Chatelle C,Fernández-Espejo D,Bekinschtein TA,Pickard JD,Laureys S,Owen AM

    更新日期:2012-03-13 00:00:00

  • Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.

    abstract:OBJECTIVE:Nonmotor symptoms (sleep dysfunction, sensory symptoms, autonomic dysfunction, mood disorders, and cognitive abnormalities) in Parkinson disease (PD) are a major cause of morbidity, yet are often underrecognized. This evidence-based practice parameter evaluates treatment options for the nonmotor symptoms of P...

    journal_title:Neurology

    pub_type: 杂志文章,实务指引

    doi:10.1212/WNL.0b013e3181d55f24

    authors: Zesiewicz TA,Sullivan KL,Arnulf I,Chaudhuri KR,Morgan JC,Gronseth GS,Miyasaki J,Iverson DJ,Weiner WJ,Quality Standards Subcommittee of the American Academy of Neurology.

    更新日期:2010-03-16 00:00:00

  • Expression of cytokines in brain lesions in subacute sclerosing panencephalitis.

    abstract::We analyzed frozen brain specimens from three patients with subacute sclerosing panencephalitis (SSPE) for the presence of interleukin (IL)-1 beta, IL-2, IL-6, tumor necrosis factor (TNF), lymphotoxin (LT), and interferon (IFN)-gamma using immunocytochemical techniques. We detected these cytokines in SSPE brain lesion...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.44.4.710

    authors: Nagano I,Nakamura S,Yoshioka M,Onodera J,Kogure K,Itoyama Y

    更新日期:1994-04-01 00:00:00

  • Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry.

    abstract::Fourteen patients with Alzheimer's disease were evaluated by psychometric testing, fluorodeoxyglucose positron emission tomography (PET), and EEG. They were divided into two groups according to the EEG findings. Group A (seven patients) had normal alpha backgrounds and group B (seven patients) had decreased alpha back...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.38.5.747

    authors: Sheridan PH,Sato S,Foster N,Bruno G,Cox C,Fedio P,Chase TN

    更新日期:1988-05-01 00:00:00

  • Increase of arginine dimethylation correlates with the progression and prognosis of ALS.

    abstract:OBJECTIVE:To investigate whether arginine methylation is altered in patients with amyotrophic lateral sclerosis (ALS) and how it affects disease severity, progression, and prognosis. METHODS:We compared the immunoreactivity of protein arginine methyltransferase 1 (PRMT1) and its products, asymmetric dimethylated prote...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000007311

    authors: Ikenaka K,Atsuta N,Maeda Y,Hotta Y,Nakamura R,Kawai K,Yokoi D,Hirakawa A,Taniguchi A,Morita M,Mizoguchi K,Mochizuki H,Kimura K,Katsuno M,Sobue G

    更新日期:2019-04-16 00:00:00

  • Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia.

    abstract::Dementia occurs infrequently in patients with giant cell (temporal) arteritis (GCA). Three elderly women with biopsy-proven GCA showed abrupt cognitive decline during periods of clinically active GCA, 1 to 6 months after diagnostic temporal artery biopsy, during periods of corticosteroid taper. One patient had additio...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.40.5.753

    authors: Caselli RJ

    更新日期:1990-05-01 00:00:00

  • The practice of neurology: Looking ahead by looking back.

    abstract::Over the last 50 years, there have been many improvements in therapy for individuals with neurologic disorders. Simultaneously, the complexity and cost of care have increased. The delivery of neurologic services is inefficient. The needs of both patients and neurologists are not being optimally addressed. Although gre...

    journal_title:Neurology

    pub_type: 历史文章,杂志文章

    doi:10.1212/WNL.0000000000001589

    authors: Ringel SP

    更新日期:2015-05-19 00:00:00

  • Penetrating war injuries of the basal forebrain: neurology and cognition.

    abstract::We compared the neurologic and cognitive performance of 15 young veterans who suffered unilateral penetrating missile wounds to the basal forebrain 15 years ago in the Vietnam War with uninjured controls and patients with lesions elsewhere in the brain. The subjects performed worse on tests of episodic memory, reasoni...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.36.4.459

    authors: Salazar AM,Grafman J,Schlesselman S,Vance SC,Mohr JP,Carpenter M,Pevsner P,Ludlow C,Weingartner H

    更新日期:1986-04-01 00:00:00

  • Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology.

    abstract::We measured the cerebral metabolic rate for glucose (CMRglc) with positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose in a 47-year-old man with trisomy 21 Down's syndrome (DS) and autopsy-confirmed Alzheimer's disease. Dementia was evident from a confirmed history of cognitive decline, memory loss, and pe...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.38.6.938

    authors: Schapiro MB,Ball MJ,Grady CL,Haxby JV,Kaye JA,Rapoport SI

    更新日期:1988-06-01 00:00:00